Basilea Pharmaceutica AG Cash Flow Reinvestment Rate
Basilea Pharmaceutica AG cash flow reinvestment rate. Basilea Pharmaceutica AG (BSLN) has a Cash Flow Reinvestment Rate of 0.06x as of December 2025, reinvesting CHF2.30 Million (capex CHF2.30 Million ) from operating cash flow of CHF39.03 Million. Explore BSLN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Basilea Pharmaceutica AG (2005–2025)
Cash flow reinvestment rate of Basilea Pharmaceutica AG from 2005 to 2025. Historical reinvestment intensity for Basilea Pharmaceutica AG across 8 annual periods. Explore reinvestment intensity of Basilea Pharmaceutica AG to see what proportion of operating cash flow is directed to capital expenditures.
Basilea Pharmaceutica AG Cash Flow Reinvestment Rate by Year (2005–2025)
Basilea Pharmaceutica AG cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for Basilea Pharmaceutica AG. For the full cash flow conversion analysis, see BSLN cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | CHF2.62 Million | CHF62.09 Million | CHF2.62 Million | ▲ +15.3% |
| 2024 | 0.04x | CHF2.72 Million | CHF74.36 Million | CHF1.71 Million | ▼ -74.8% |
| 2023 | 0.15x | CHF2.07 Million | CHF14.24 Million | CHF1.03 Million | ▼ -98.9% |
| 2022 | 13.46x | CHF94.95 Million | CHF7.06 Million | CHF3.30 Million | ▲ +321.5% |
| 2017 | 3.19x | CHF60.71 Million | CHF19.01 Million | CHF711.00K | ▲ +35705.9% |
| 2012 | 0.01x | CHF1.32 Million | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF1.24 Million | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF1.20 Million | CHF34.38 Million | CHF1.20 Million | — |